237 related articles for article (PubMed ID: 2785481)
1. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization.
Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C
Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481
[TBL] [Abstract][Full Text] [Related]
2. Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells.
Kunicka JE; Fox FE; Seki H; Oleszak EL; Platsoucas CD
Hum Antibodies Hybridomas; 1991 Jul; 2(3):160-9. PubMed ID: 1873505
[TBL] [Abstract][Full Text] [Related]
3. A new method for the development of human T-T cell hybrids without the use of HAT medium.
Platsoucas CD; Calvelli TA; Kunicka JA
Hybridoma; 1987 Dec; 6(6):589-603. PubMed ID: 3501764
[TBL] [Abstract][Full Text] [Related]
4. Hybridoma-derived human suppressor factors: differential effects on mouse lymphocytes.
Telerman A; Merluzzi VJ; Calvelli TA; Kunicka JE; Platsoucas CD
Hybridoma; 1989 Feb; 8(1):25-36. PubMed ID: 2784404
[TBL] [Abstract][Full Text] [Related]
5. Human hybridoma-derived suppressor factor 160 and transforming growth factor-beta are different molecules.
Fox FE; Oleszak EL; Chen PF; Platsoucas CD
Lymphokine Cytokine Res; 1992 Dec; 11(6):307-15. PubMed ID: 1477184
[TBL] [Abstract][Full Text] [Related]
6. Human immunosuppressive factors produced by T cell hybridoma.
Tsunetsugu-Yokota Y; Honda M; Tokunaga T
Hybridoma; 1989 Aug; 8(4):391-400. PubMed ID: 2789176
[TBL] [Abstract][Full Text] [Related]
7. Human T-T cell hybridomas: development and applications.
Fox FE; Platsoucas CD
Hum Antibodies Hybridomas; 1990; 1(1):3-9. PubMed ID: 2103350
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
[TBL] [Abstract][Full Text] [Related]
10. Production of human suppressor T cell hybridomas.
Greene WC; Fleisher TA; Nelson DL; Waldmann TA
J Immunol; 1982 Nov; 129(5):1986-92. PubMed ID: 6214585
[TBL] [Abstract][Full Text] [Related]
11. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
12. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
13. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
14. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
Butler JL; Ambrus JL; Fauci AS
J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
[TBL] [Abstract][Full Text] [Related]
16. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. IV. Murine T hybridoma cells exhibit differential accessory cell requirements for activation by M. arthritidis T cell mitogen, concanavalin A, or hen egg-white lysozyme.
Cole BC; Araneo BA; Sullivan GJ
J Immunol; 1986 May; 136(10):3572-8. PubMed ID: 3486214
[TBL] [Abstract][Full Text] [Related]
18. Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.
Friedman AM; Ptak W; Brewer E; Green DR; Reuter PA; Flood PM
Immunology; 1990 Oct; 71(2):282-9. PubMed ID: 1699882
[TBL] [Abstract][Full Text] [Related]
19. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
Denis KA; Wall R; Saxon A
J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
[TBL] [Abstract][Full Text] [Related]
20. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
Kikuchi Y; Kato R; Sano Y; Takahashi H; Kanatani T; Takatsu K
J Immunol; 1986 May; 136(10):3553-60. PubMed ID: 2939132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
